Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P386: Methotrexate use in combination with anti-TNFα agents in IBD: A tertiary centre experienceECCO '18 Vienna
Year: 2018
Authors:

W. Waddingham*, A. Nwaogu, E. Michael, L. Whitley, H. Parker, R. Kettle, I. Parisi, E. Seward, S. McCartney, S. Bloom, R. Vega, F. Rahman, S. Mehta

University College London Hospitals NHS Foundation Trust, Gastroenterology, London, UK

P387: Infliximab therapeutic drug monitoring test validated for measuring CT-P13 and SB2 biosimilarsECCO '18 Vienna
Year: 2018
Authors:

M.B. Ruiz-Agüello*, A. Maguregui, A. Martínez, D. Nagore

Progenika Biopharma SA, R&D Department, Derio, Spain

P388: Response to IV steroid therapy in acute severe ulcerative colitis (ASUC) is not altered by admission to a tertiary referral centre: The NHS Lothian experienceECCO '18 Vienna
Year: 2018
Authors:

T. Manship*, R. Grant, F. Jagger, R. Lynch, C. Lees, J. Satsangi, I. Arnott

Western General Hospital, Gastroenterology, Edinburgh, UK

P390: Methotrexate is not superior to placebo in maintaining remission in patients with ulcerative colitis: results from the MERIT-UC studyECCO '18 Vienna
Year: 2018
Authors:

H. Herfarth1*, E.L. Barnes1, S. Jackson1, J.F. Valentine2, J. Hanson3, P.D.R. Higgins4, K.L. Isaacs1, M.T. Osterman5, B.E. Sands6, J.D. Lewis5, MERIT-UC study group

1University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, USA, 2University of Utah, Department of Medicine, Utah, USA, 3Carolinas Health Care, Medicine, Charlotte, USA, 4University of Michigan, Department of Internal Medicine, Department of Gastroenterology, Ann Arbor, USA, 5University of Pennsylvania School of Medicine, Department of Gastroenterology, Inflammatory Bowel Disease Center, Philadelphia, USA, 6Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York City, USA

P391: The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registryECCO '18 Vienna
Year: 2018
Authors:

M. Guasch1, A. Clos2, I. Ordás3,4, V. García-Sánchez5, J.P. Gisbert4,6, C. Taxonera7, I. Vera8, M. Mínguez9, J. Guardiola10, A. López-Sanromán11, M. Rivero-Tirado12, P. Nos13, F. Gomollón4,14, A.Y. Carbajo15, R. de Francisco16, M.D. Martín-Arranz17, E. Garcia-Planella18, S. García-López19, L. de Castro20, X. Calvet4,21, R. Camargo22, M. Esteve4,23, B. Sicilia24, M. Andreu25, A. Macho26, M. Piqueras27, F. Bermejo28, A. Gutiérrez29, D. Busquets30, P. Martínez-Montiel31, J. Hinojosa32, J.L. Pérez-Calle33, L. Bujanda34, A. Rodríguez-Pérez35, R. Lorente36, N. Jiménez37, M. Navarro-Llavat38, J.L. Cabriada39, P. Camo40, M. Van Domselaar41, E. Rodríguez-González42, C. Rodríguez-Gutiérrez43, J.M. Huguet44, A.J. Lucendo45, F. Argüelles46, P. Almela47, O. Merino48, M. Calafat49, M. Ogueta50, M. Charro51, J. Llaó52, C. Muñoz53, L. Ramos54, Á. Abad55, Ó. Roncero56, M. Barreiro-de-Acosta57, E. Sesé58, M. Mañosa2,4, E. Domènech2,4*

1Hospital San Jorge, Surgery, Huesca, Spain, 2Hospital Germans Trias i Pujol, Gastroenterology, Badalona, Spain, 3Hospital Clínic, Gastroenterology, Barcelona, Spain, 4CIBERehd, Madrid, Spain, 5Hospital Reina Sofía, Gastroenterology, Córdoba, Spain, 6Hospital de la Princesa, Gastroenterology, Madrid, Spain, 7Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain, 8Hospital Universitario Puerta de Hierro, Gastroenterology, Madrid, Spain, 9Hospital Clínico de Valencia, Gastroenterology, Valencia, Spain, 10Hospital Universitari de Bellvitge, Gastroenterology, L'Hospitalet de Llobregat, Spain, 11Hospital Ramón y Cajal, Gastroenterology, Madrid, Spain, 12Hospital Marqués de Valdecilla, Gastroenterology, Santander, Spain, 13Hospital Politècnic La Fe, Gastroenterology, Valencia, Spain, 14Hospital Clínico Lozano Blesa, Gastroenterology, Zaragoza, Spain, 15Hospital Río Hortega, Gastroenterology, Valladolid, Spain, 16Hospital Universitario Central de Asturias, Gastroenterology, Ovideo, Spain, 17Hospital La Paz, Gastroenterology, Madrid, Spain, 18Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain, 19Hospital Universitario Miguel Servet, Gastroenterology, Zaragoza, Spain, 20Complejo Hospitalario Universitario de Vigo, Gastroenterology, Vigo, Spain, 21Hospital Parc Taulí, Gastroenterology, Sabadell, Spain, 22Hospital Clínico Virgen de la Victoria, Gastroenterology, Málaga, Spain, 23Mútua de Terrassa, Gastroenterology, Terrassa, Spain, 24Complejo Hospitalario Universitario de Burgos, Gastroenterology, Burgos, Spain, 25Hospital Parc del Mar, Gastroenterology, Barcelona, Spain, 26Hospital Clínico Universitario de Valladolid, Gastroenterology, Valladolid, Spain, 27Consorci Sanitari de Terrassa, Gastroenterology, Terrassa, Spain, 28Hospital Universitario Fuenlabrada, Gastroenterology, Fuenlabrada, Spain, 29Hospital General Universitario de Alicante, Gastroenterology, Alicante, Spain, 30Hospital Dr. Josep Trueta, Gastroenterology, Girona, Spain, 31Hospital 12 de Octubre, Gastroenterology, Madrid, Spain, 32Hospital de Manises, Gastroenterology, Manises, Spain, 33Hospital Universitario Fundación de Alcorcón, Gastroenterology, Alcorcón, Spain, 34Hospital de Donostia, Gastroenterology, Donostia, Spain, 35Hospital Universitario de Salamanca, Gastroenterology, Salamanca, Spain, 36Hospital General de Ciudad Real, Gastroenterology, Ciudad Real, Spain, 37Hospital General Universitario de Elche, Gastroenterology, Elche, Spain, 38Hospital Moisès Broggi, Gastroenterology, Sant Joan Despí, Spain, 39Hospital de Galdakao, Gastroenterology, Galdakao, Spain, 40Hospital San Jorge, Gastroenterology, Huesca, Spain, 41Hospital de Torrejón, Gastroenterology, Torrejón de Ardoz, Spain, 42Hospital Nuestra Señora de la Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain, 43Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain, 44Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain, 45Hospital General de Tomelloso, Gastroenterology, Tomelloso, Spain, 46Hospital Virgen de la Macarena, Gastroenterology, Sevilla, Spain, 47Hospital General de Castelló, Gastroenterology, Castelló, Spain, 48Hospital de Cruces, Gastroenterology, Barakaldo, Spain, 49Hospital Son Llàtzer, Gastroenterology, Mallorca, Spain, 50Hospital Universitario de Áraba, Gastroenterology, Vitoria, Spain, 51Hospital Royo Villanova, Gastroenterology, Zaragoza, Spain, 52Hospital Sant Joan de Déu - Althaia, Gastroenterology, Manresa, Spain, 53Hospital de Basurto, Gastroenterology, Basurto, Spain, 54Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain, 55Hospital de Viladecans, Gastroenterology, Viladecans, Spain, 56Hospital Mancha Centro, Gastroenterology, Alcázar de San Juan, Spain, 57Complejo Hospitalario Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain, 58Hospital Universitari Arnau de Vilanova, Gastroenterology, Lleida, Spain

P392: Comprehensive video capsule endoscopy-based monitoring predicts short and long-term risk of disease flares in small bowel Crohn’s disease: A prospective cohort studyECCO '18 Vienna
Year: 2018
Authors:

S. Ben-Horin1*, A. Lahat1, M.M. Amitai2, E. Klang2, D. Yablecovitch1, S. Neuman1, N. Levhar1, L. Selinger1, M. Bubis1, O. Picard1, D. Turner3, S. Odes4, H. Yanai5, Y. Chowers6, I. Dotan5, U. Kopylov1, R. Eliakim1

1Sheba Medical Center and Sackler School of Medicine, Gastroenterology, Tel Hashomer, Israel, 2Sheba Medical Center, Department of Radiology, Tel Hashomer, Israel, 3Sharei Zedek Medical Center, Department of Gastroenterology, Jerusalem, Israel, 4Ben-Gurion University of the Negev and Soroka Medical Center, Department of Gastroenterology, Beer-Sheva, Israel, 5Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 6Rambam Health Care Campus and Bruce Rappaport School of Medicine, Technion Institute of Technology, Department of Gastroenterology, Haifa, Israel

P393: Long-term prediction of infliximab response using CD-62L shedding assay: Longitudinal data from 5-year study in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Macpherson1, F. Bravo2, P. Andrew1, E. Slack1, N. Patuto1, J. Cahenzli1, K.D. McCoy1, A.J. Macpherson2, P. Juillerat1,2*

1University Bern, Maurice E Müller Laboratories, Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital, Bern, Switzerland, 2Clinic for Visceral Surgery and Medicine, Gastroenterology, Bern, Switzerland

P394: Preoperative serum vedolizumab levels do not predict postoperative outcomes in inflammatory bowel disease (IBD)ECCO '18 Vienna
Year: 2018
Authors:

N. Lopez1, K. Zaghiyan1, G. Melmed1, D. McGovern1, A. Jain2, S. Targan1, P. Fleshner1*, C. Landers1

1Cedars-Sinai Medical Center, Los Angeles, USA, 2Prometheus Laboratories, San Diego, USA

P395: Dermatological reactions associated with anti–TNF therapy in inflammatory bowel disease- an 12 year experienceECCO '18 Vienna
Year: 2018
Authors:

A. Bhandare*, R. Diyar, J. Taylor, J.K. Limdi

Pennine Acute Hospitals Trust, Gastroenterology, Manchester, UK

P396: Pharmacokinetics, immunogenicity and clinical outcomes of golimumab from the PURSUIT PEDS ulcerative colitis study long-term (through week 126) extensionECCO '18 Vienna
Year: 2018
Authors:

J. Hyams1, C.D. O’Brien2, L. Padgett2, J. Rosh3, D. Turner4, G. Veereman5, A. Griffiths6, M.B. Heyman7, G. Wahbeh8, J. Adedokun2, R. Strauss2, D. Chan2, J. Lynch2*

1Connecticut Children’s Medical Center, Hartford, USA, 2Janssen Research and Development, LLC, Spring House, USA, 3Goryeb Children's Hospital/Atlantic Health, Pediatric Gastroenterology, Clinical Development and Research Affairs, Morristown, USA, 4The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel, 5Free University Brussels, Brussels, Belgium, 6The Hospital for Sick Children, University of Toronto, Toronto, Canada, 7University of California San Francisco, Gastroenterology Division, San Francisco, USA, 8Seattle Children's Hospital, Seattle, USA

P397: Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida RegistryECCO '18 Vienna
Year: 2018
Authors:

M. Chaparro1,2,3,4*, A. Garre1,2,3,4, I. Alfaro4,5, M. Iborra4,6, P. Mesonero7, I. Vera Mendoza8, A. Rodríguez9, J. Miquel-Cusachs10, S. Riestra11, P. Navarro12, L. De Castro Parga13, C. González-Muñoza14, M. Rivero15, M. Mañosa4,16, L. Fernández Salazar17, N. Jiménez18, J. Guardiola19, J. Cabriada20, A. Gutiérrez Casbas4,21, B. Sicilia22, J.L. Pérez Calle23, M. Piqueras24, A. Algaba25, O. Roncero26, A. Bargallo27, E. Sainz28, J. Barrio29, X. Calvet4,30, A. García31, M. Llorente Barrio32, R. Llorente Poyatos33, P. Almela34, R. Madrigal35, A.J. Lucendo Villarín36, R. Pajares37, M. Van Domselaar38, J. Legido Gil39, J.P. Gisbert1,2,3,4

1Hospital Universitario de La Princesa, Gastroenterology Unit, Madrid, Spain, 2Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain, 3Universidad Autónoma de Madrid, Madrid, Spain, 4Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, 5Hospital Clínico y Provincial de Barcelona, Gastroenterology Unit, Barcelona, Spain, 6Hospital Universitario y Politécnico de La Fe, Gastroenterology Unit, Valencia, Spain, 7Hospital Universitario Ramón y Cajal, Gastroenterology Unit, Madrid, Spain, 8Hospital Universitario Puerta de Hierro, Gastroenterology Unit, Madrid, Spain, 9Hospital Universitario De Salamanca, Gastroenterology Unit, Salamanca, Spain, 10Hospital Universitario de Gerona Dr Josep Trueta, Gastroenterology Unit, Gerona, Spain, 11Hospital Universitario Central de Asturias, Gastroenterology Unit, Oviedo, Spain, 12Hospital Clínico Universitario de Valencia, Gastroenterology Unit, Valencia, Spain, 13Complejo Hospitalario Universitario de Vigo, Gastroenterology Unit, Vigo, Spain, 14Hospital de La Santa Creu i Sant Pau, Gastroenterology Unit, Barcelona, Spain, 15Hospital Universitario de Marqués de Valdecilla, Gastroenterology Unit, Santander, Spain, 16Hospital Universitario Germans Trias i Pujol, Gastroenterology Unit, Badalona, Spain, 17Hospital Clínico Universitario de Valladolid, Gastroenterology Unit, Valladolid, Spain, 18Hospital General Universitario de Elche, Gastroenterology Unit, Elche, Spain, 19Hospital Universitario de Bellvitge, Gastroenterology Unit, Hospitalet de Llobregat, Spain, 20Hospital de Galdakao-Usansolo, Gastroenterology Unit, Vizcaya, Spain, 21Hospital General Universitario de Alicante, Gastroenterology Unit, Alicante, Spain, 22Hospital Universitario de Burgos, Gastroenterology Unit, Burgos, Spain, 23Hospital Universitario Fundación Alcorcón, Gastroenterology Unit, Alcorcón, Spain, 24Consorci Sanitari Terrassa, Gastroenterology Unit, Tarrasa, Spain, 25Hospital Universitario de Fuenlabrada, Gastroenterology Unit, Fuenlabrada, Spain, 26Complejo Hospitalario la Mancha Centro, Gastroenterology Unit, Alcázar de San Juan, Spain, 27Hospital de Sant Joan Despí Moisès Broggi, Gastroenterology Unit, Sant Joan Despí, Spain, 28Hospital Universitario Arnau de Vilanova, Gastroenterology Unit, Lérida, Spain, 29Hospital Universitario Rio Hortega, Gastroenterology Unit, Valladolid, Spain, 30Consorcio Corporación Sanitaria Parc Taulí, Gastroenterology Unit, Sabadell, Spain, 31Hospital Virgen de La Victoria, Gastroenterology Unit, Málaga, Spain, 32Hospital Universitario Miguel Servet, Gastroenterology Unit, Zaragoza, Spain, 33Hospital General Universitario de Ciudad Real, Gastroenterology Unit, Ciudad Real, Spain, 34Hospital General Universitario de Castellón, Gastroenterology Unit, Castellón, Spain, 35Complejo Hospitalario de Palencia, Gastroenterology Unit, Palencia, Spain, 36Hospital Público General de Tomelloso, Gastroenterology Unit, Tomelloso, Spain, 37Hospital Universitario Infanta Sofía, Gastroenterology Unit, San Sebastián de los Reyes, Spain, 38Hospital Universitario de Torrejón, Gastroenterology Unit, Torrejón de Ardoz, Spain, 39Hospital General de Segovia, Gastroenterology Unit, Segovia, Spain

P398: Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC)ECCO '18 Vienna
Year: 2018
Authors:

T. Naftali1,2*, L. Bar Lev Schlieder3, F. Sklerovsky Benjaminov1,2, I. Lish2,4, J. Hirsch4, F.M. Konikoff1,2

1Meir medical center, Gastroenterology, Kfar Saba, Israel, 2Tel Aviv University Sackler School of Medicine, Internal Medicine, Tel Aviv, Israel, 3Bar Ilan University, Behavioural Sciences, Tel Aviv, Israel, 4Meir Medical Center, Department of Gastroenterology and Hepatology, Kfar Saba, Israel

P399: Vedolizumab therapy results in reduced hospitalisation and steroid use over 1-year: Results from the Scottish vedolizumab consortiumECCO '18 Vienna
Year: 2018
Authors:

N. Plevris1*, C.S. Chuah1, R. Allen2, P. Baker2, P. Brennan3, A. Churchhouse1, E. Donoghue4, D. Gaya2, H. Jafferbhoy5, P. Jenkinson1, G. Jones1, J. Macdonald2, M. MacMaster2, C. Mowat3, G. Naismith6, L. Potts7, E. Saffouri2, J.P. Seenan2, A. Sengupta5, P. Shasi3, J. Todd3, J. Veryan2, A. Watson8, D. Watts4, I. Arnott1, C. Lees1, M. Groome3 M. Calvo1*, I. Alonso2, K. Villa1,3, V. Matallana1, Y. González Lama1, M.I. Vera1, A. Sanchez Movilla2, P. Calvo2, A. Royuela4, L. Abreu1

1NHS Lothian, Gastroenterology, Edinburgh, UK, 2NHS Greater Glasgow and Clyde, Gastroenterology, Glasgow, UK, 3NHS Tayside, Gastroenterology, Dundee, UK, 4NHS Forth Valley, Gastroenterology, Forth Valley, UK, 5NHS Fife, Gastroenterology, Kirkcaldy, UK, 6NHS Lanarkshire, Gastroenterology, Lanarkshire, UK, 7NHS Highlands, Gastroenterology, Inverness, UK, 8NHS Highlands, Colorectal Surgery, Inverness, UK 1Hospital Universitario Puerta de Hierro Majadahonda, IBD Unit, Gastroenterology and Hepatology Department, Majadahonda, Madrid, Spain, 2Hospital Universitario Puerta de Hierro Majadahonda, IBD Unit, Colorectal Surgery Department., Majadahonda, Madrid, Spain, 3Centro de Gastroenterologia, Ciudad Sanitaria Dr. Luis E. Aybar, IBD Unit. Gastroenterology and Hepatology Department, Santo Domingo, Spain, 4Hospital Universitario Puerta de Hierro Majadahonda, Clinical Biostatistics Unit, Biomedical Sciences Research Institute Puerta de Hierro, Majadahonda, Madrid, Spain

P401: Reduction of dosing intervals is the preferable dose optimisation strategy for infliximab to suppress formation of anti-drug antibodiesECCO '18 Vienna
Year: 2018
Authors:

W. Reinisch1*, A. Eser1, S. Schreiber2, H. Kim3, D. Mould4

1Medical University of Vienna, Department of Internal Medicine III, Gastroenterology and Hepatology, Vienna, Austria, 2Christian Albrechts University Kiel, Department of General Internal Medicine I; Institute of Clinical Molecular Biology, Kiel, Germany, 3Celltrion Healthcare Co. Ltd., Incheon, South Korea, 4Projections Research, Inc., Projections Research Inc., Phoenixville, USA

P402: Interstitial and granulomatous lung disease in inflammatory bowel disease patientsECCO '18 Vienna
Year: 2018
Authors:

E. Eliadou1*, J. Moleiro2, D.G. Ribaldone3, M. Astegiano3, K. Rothfuß4, C. Taxonera5, B. Verstockt6, F. Ghalim7, F. Carbonnel7, S. Festa8, A. Berrozpe9, L. Maia10, E. Savarino11, P. Ellul12, E. Zagorowicz13, S. Vavricka14, M. Calvo15, I. Koutroubakis16, F. Hoentjen17, L. Fernández Salazar18, F. Callela19, F. Cañete Pizarro20, K. Soufleris21, E. Sonnenberg22, M. Cavicchi23, G. Fiorino24,25

1Manchester Royal Infirmary, Department of Gastroenterology, Manchester, UK, 2Instituto Portugues de Oncologia de Lisboan Francisco Gentil, Lisboa, Portugal, 3Gastroenterologia-U, Città della Salute e della Scienza di Torino, Turin, Italy, 4Robert-Bosch Hospital, Gastroenterology Department, Stuttgart, Germany, 5Servicio Aparato Digestivo, Hospital Clínico San Carlos, IBD unit, Madrid, Spain, 6University Hospitals Leuven, Gastroenterology Department, Leuven, Belgium, 7Kremlin Bicêtre Hospital, AP-HP, University Paris Sud, Gastroenterology Department, Paris, France, 8Ospedale S. Filippo Neri, Gastroenterology Department, Rome, Italy, 9Bellvitge's hospital, Gastroenterology Department, Barcelona, Spain, 10Centro Hospitalar do Porto, Gastroenterology Department, Porto, Portugal, 11University of Padua, Padua, Italy, 12Mater Dei Hospital, Msida, Malta, 13The Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology, Gastroenterology Department, Warsaw, Poland, 14Triemli Hospital, Zurich, Switzerland, 15Hospital Universitario Puerta de Hierro Madrid, Madrid, Spain, 16University of Crete, Heraklion, Greece, 17Radboud University Medical Center, Nijmegen, The Netherlands, 18Clínico Universitario de Valladolid, Valladolid, Spain, 19UOC Gastroenterologia, Ospedale San Giuseppe, Florence, Italy, 20Hospital Universitari Germans Trias i Pujol in Badalona, Barcelona, Spain, 21Theagenion Cancer Hospital of Thessaloniki, Thessaloniki, Greece, 22Charité-Universitätsmedizin Berlin, Berlin, Germany, 23Clinique de Bercy, Paris, France, 24RCCS Istituto Clinico Humanitas, Gastroenterology Department, Rozzano, Milan, Italy, 25For ECCO CONFER Steering Committee, Vienna, Austria

P403: Treatment naïve newly diagnosed patients with Crohn's disease have microbial dysbiosis correlated with disease activity and faecal calprotectin—results from a prospective inception cohortECCO '18 Vienna
Year: 2018
Authors:

H. Yanai1,2*, I. Goren3,4, L. Reshef5, L. Godny1,2, K. Yadgar1, K. Zonenesain1, I. Dotan2,3

1IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel, 2Sackler Faculty of Medicine, Tel Aviv Israel, Tel Aviv, Israel, 3Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel, 4Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 5Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel

P404: Development of anti-drug antibodies among those treated with adalimumab and ABP 501 and its impact on serum drug concentration in randomised controlled studiesECCO '18 Vienna
Year: 2018
Authors:

V. Chow*, A. Kaliyaperumal, N. Zhang, J. Miller, D. Mytych, M. Starcevic Manning, I. Wala, H. Wang, E. Krishnan

Amgen Inc., Biosimilars, Thousand Oaks, USA

P405: 5-ASA prescription trends over time in inflammatory bowel disease 1996 to 2015–A UK population-based studyECCO '18 Vienna
Year: 2018
Authors:

V. Jairath1,2*, S. Hokkanen3, L. Guizzetti2, N. Boxall3, S. Campbell-Hill4, H. Patel4

1Western University, Department of Medicine, London, Ontario, Canada, 2Robarts Clinical Trials Inc., London, Ontario, Canada, 3IQVIA, London, UK, 4Takeda International–UK Branch, London, UK

P406: Malnutrition during hospitalisation for acute severe IBD is associated with increased risk of relapseECCO '18 Vienna
Year: 2018
Authors:

K. Kulmala1*, J. Björk2, S. Andersson3, A.-S. Backman1,2, C.R.H. Hedin2, F. Bresso2

1Karolinska Institutet, Department of Medicine, Solna, Unit of Internal Medicine, Stockholm, Sweden, 2Karolinska University Hospital, Gastroenterology Unit, Patient Area Gastroenterology, Dermatovenereology and Rheumatology, Stockholm, Sweden, 3Karolinska University Hospital, Department of Clinical Nutrition, Stockholm, Sweden